ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|
 
Print Page
Email Article

NIAID Provides Access to Latest Immune Research Technology

  [ 32 votes ]   [ Post a Comment ]
www.ProHealth.com • April 4, 2002

previous article next article



NATIONAL INSTITUTES OF HEALTH - NIH NEWS RELEASE

National Institute of Allergy and Infectious Diseases

Thursday, April 4, 2002

Finding new ways to stimulate immunity against microbes and tumors requires knowing the cells and molecules involved in immune recognition. In particular, researchers seek to identify which molecules are recognized by which T cells, a central component of specific immune responses. To help scientists accomplish that goal, the National Institute of Allergy and Infectious Diseases (NIAID) has renewed and expanded its contract for a facility that provides tetramers, a powerful new technology in T-cell research. The facility, located at Atlanta's Emory University, will enable investigators worldwide to make rapid discoveries in vaccine research, cancer treatment and biodefense.

Tetramer technology can quickly identify those T cells
involved in a given immune response. Tetramers can help scientists rapidly test the activity of new vaccines or confirm which parts of invading microbes stimulate an immune response. In cancer research, tetramers can determine which components of a tumor cell trigger the body's defenses.

Tetramers are complexes of four identical copies of the key proteins that can stimulate specific T cells. A T cell is activated when it recognizes a fragment of a target protein on the surface of a neighboring cell. Those fragments, called peptides, are held in place on the cell's surface by proteins known as MHC molecules. The T cell must grab both the peptide and the MHC molecule before it is stimulated.

Tetramers are MHC-peptide complexes that have been
untethered from the cell. They will attach only to T cells that recognize a specific complex and can therefore flag all T cells that respond to a given trigger.

Tetramers offer vast improvements over previous procedures
for screening T-cell responses, but not all laboratories possess the resources required to synthesize and assemble the proteins. The NIAID facility at Emory provides tetramers to researchers from around the world, allowing them to conduct experiments that otherwise would be difficult or impossible to complete.

Since opening for business in 1999, the tetramer facility
has provided more than 1,200 tetramers to 350 researchers
from 19 different countries. Those tetramers have allowed scientists to make important discoveries about many diseases, including hepatitis C, herpes, HIV and multiple cancers.

Under the terms of the new contract, tetramer facility scientists will provide so-called class I and class II tetramers. To date, the facility has provided only class I tetramers, which are easier to synthesize and which typically identify a subset of T cells that kill infected cells and tumor cells. Class II tetramers, which will be available soon, identify the helper T cells that promote antibody production and help coordinate immune responses to infection and vaccination.

The renewed five-year contract, at an estimated $980,000
per year, will be funded by NIAID including support from
the National Cancer Institute (NCI). The facility will
remain under the direction of Emory's John Altman, Ph.D.

Information on the facility can be found at http://www.niaid.nih.gov/reposit/tetramer/index.html.

Researchers who want to receive tetramers must first submit
a request form, available on the Web site. Investigators
must provide their peptide of interest, which will be incorporated into the tetramer of their choice. The service is free of charge, but recipients pay for all shipping. All researchers are eligible for reagents, not just those whose research is funded by NIAID or NCI grants.

NIAID is a component of the National Institutes of Health (NIH). NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

Press releases, fact sheets and other NIAID-related
materials are available on the NIAID Web site at http://www.niaid.nih.gov.

Contact: Sam Perdue at sp189u@nih.gov


previous article
  Rating 2.9 (32 votes) next article




DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 




[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Your Next Order

Featured Products
OsteoTec™ UC-II® OsteoTec™ UC-II®
A True Breakthrough in Joint health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Natural Resveratrol Natural Resveratrol
Powerful Antioxidant Support + Positive Anti-aging Effects
Vitamin D3 5000 IU Vitamin D3 5000 IU
Give your body a boost with the sunshine vitamin

Most Viewed Articles
What's the Hidden Cause Behind YOUR Fibromyalgia Flares? [more]

Pridgen Reports Fibromyalgia Antiviral Trial Results “Very Positive”: Predicts New Approach Will Be ... [more]

Massage Therapy Studies for Fibromyalgia Reviewed [more]

How to Limit or Minimize Your Fibromyalgia Flare [more]

Breaking News: FDA’s Sneak Attempt to Ban Another B Vitamin [more]

Mitochondrial Dysfunction, Post-Exertional Malaise and CFS/ME [more]

The Devil Is In The Details – A Herpes Simplex Virus Inquiry For Fibromyalgia and Chronic Fatigue Sy... [more]

FDA Says Sponsors of Chronic Fatigue Syndrome Drugs can Rely on Patient-Reported Outcomes [more]

Sensory Overload: Sources and Strategies [more]

Sympathetic Nervous System Dysfunction in FIbromyalgia and Overlapping Conditions [more]


FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing